Skip to content

Dr. Coldea Pediatrics

Active
Private limited companyfounded 20242 yrs activede Broquevillelaan 204, 1200 Sint-Lambrechts-Woluwe, BelgiumKBO/BCE: BE 1013.812.722
Summary

Dr. Coldea Pediatrics has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€1,384) and a net result of -€3,384. Its solvency ranks better than 5% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
44 / 100
Weak
Negative equity caps the score. Every signal that weighs is under Signals.
Axes
Profitability62
Solvency23
Growth-
Track record67
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity tight (current ratio 1.31; short-term debt: 50.4% and cash: 5.1% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-2.3%
Return on assets
-5.5%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-09-2026, 37 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
37 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Dr. Coldea Pediatrics was incorporated on 19 September 2024 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
-€1,384
Total assets
€61,221
Net result
-€3,384
Working capital
€9,686

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €61,221
Fixed assets €20,687
Current assets €40,533
Equity and liabilities
Equity-€1,384
Debt€62,605
Equity is negative: debt (€62,605) exceeds the balance-sheet total (€61,221).
Key figures and ratios
2025 value
EBITDA
€19,302
Cash flow
€11,003
Solvency
-2.3%
Current ratio
1.31
ROA
-5.5%
Interest coverage
32.05
Debt
€62,605
Debt ≤ 1 year
€30,848
Debt > 1 year
€31,678
Income taxes
€7,701
Staff costs
€3,518
No debt to equity: equity is negative, so debt divided by equity means nothing.

Peer companies

Historical observation

Of the 1,555 companies that looked in July 2024 the way this one looks now, 4.6% went bankrupt within 24 months and 92% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a small loss
4.6% went bankrupt
3.6% stopped otherwise
92% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.5% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,555 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 39 lines
Balance sheet Code2025
Assets
Total assets20/58€61,221
Fixed assets21/28€20,687
Tangible fixed assets22/27€20,687
Furniture and vehicles24€16,263
Other tangible fixed assets26€4,424
Current assets29/58€40,533
Amounts receivable within one year40/41€36,898
Trade receivables40€23,803
Other amounts receivable41€13,094
Cash at bank and in hand54/58€3,118
Deferred charges and accrued income490/1€517
Equity and liabilities
Total equity and liabilities10/49€61,221
Equity10/15-€1,384
Contributions10/11€2,000
Profit (loss) carried forward14-€3,384
Amounts payable17/49€62,605
Amounts payable after more than one year17€31,678
Financial debts170/4€31,678
Amounts payable within one year42/48€30,848
Current portion of amounts payable after more than one year42€7,115
Trade debts44€14,554
Suppliers440/4€14,554
Taxes, remuneration and social security45€9,179
Taxes450/3€9,179
Accrued charges and deferred income492/3€79
Income statement Code2025
Remuneration, social security and pensions62€3,518
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,387
Other operating charges640/8€32,095
Gross operating margin9900€54,915
Operating profit (loss)9901€4,916
Financial income75/76B€4
Recurring financial income75€4
Financial charges65/66B€602
Recurring financial charges65€602
Profit (loss) for the period before taxes9903€4,317
Income taxes67/77€7,701
Profit (loss) for the period9904-€3,384
Profit (loss) for the period to be appropriated9905-€3,384
Appropriation of the result
Profit (loss) to be appropriated9906-€3,384

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Remuneration, social security and pensions62€3,518
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,387
Other operating charges640/8€32,095
Gross operating margin9900€54,915
Operating profit (loss)9901€4,916
Financial income75/76B€4
Recurring financial income75€4
Financial charges65/66B€602
Recurring financial charges65€602
Profit (loss) for the period before taxes9903€4,317
Income taxes67/77€7,701
Profit (loss) for the period9904-€3,384
Profit (loss) for the period to be appropriated9905-€3,384
Line2025
Assets
Total assets20/58€61,221
Fixed assets21/28€20,687
Tangible fixed assets22/27€20,687
Furniture and vehicles24€16,263
Other tangible fixed assets26€4,424
Current assets29/58€40,533
Amounts receivable within one year40/41€36,898
Trade receivables40€23,803
Other amounts receivable41€13,094
Cash at bank and in hand54/58€3,118
Deferred charges and accrued income490/1€517
Equity and liabilities
Total equity and liabilities10/49€61,221
Equity10/15-€1,384
Contributions10/11€2,000
Profit (loss) carried forward14-€3,384
Amounts payable17/49€62,605
Amounts payable after more than one year17€31,678
Financial debts170/4€31,678
Amounts payable within one year42/48€30,848
Current portion of amounts payable after more than one year42€7,115
Trade debts44€14,554
Suppliers440/4€14,554
Taxes, remuneration and social security45€9,179
Taxes450/3€9,179
Accrued charges and deferred income492/3€79
Line2025
Profit (loss) for the period9904-€3,384
+ Depreciation and write-downs630€14,387
Operating cash flow (approximation)€11,003

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
06-09
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 37 days late
NBB filing
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 2 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Sint-Lambrechts-Woluwe · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
516 m²
Building footprint
314 m²
Volume, LiDAR
6,894 m³
Parcel 21673D0117/00T029, Brussels · tallest building 28.6 m, ±8 floors. Linked by address, not a title deed.
19 companies at this address See who is registered here
1 establishment unit
Dr. Coldea Pediatrics
de Broquevillelaan 204, 1200 Sint-Lambrechts-WoluweSpecialist medical practice
since 20242.364.116.365
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21673D0117/00T029 Brussels 516 m² 1 · 314 m² 28.6 m · 8 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 16,625 companies in this sector we hold annual accounts for 7,989. See the whole sector

Company details

Identification
Legal formPrivate limited company
Founded19-09-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:1013812722
Also 9925:BE1013812722
Registered 08-04-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.